Sale!

LENRIS 4MG

LENVATINIB

MRP : MRP 1,828.00
Price : 1,300.00
You Save : 528.00 (28.88%)

10 Capsule(s) In A Strip

Buy Now

Lenris 4mg Capsule contains the active ingredient Lenvatinib. This medication is a tyrosine kinase inhibitor used for progressive or advanced thyroid cancer when radioactive iodine therapy is ineffective. Additionally, it is prescribed for liver cancer patients who have not received prior treatment and are not candidates for surgical intervention.

Anaplastic Thyroid Carcinoma (Advanced thyroid cancer) typically affects individuals over the age of 60. It is marked by an enlarged, hard thyroid gland and voice hoarseness resulting from nerve paralysis in the larynx. Hepatocellular carcinoma (liver cancer) arises from existing liver issues such as cirrhosis or chronic hepatitis B infection. Individuals who have experienced an allergic reaction to Lenris 4mg Capsule or any of its ingredients should avoid this medication. Furthermore, patients must notify their dentist or oral surgeon about their use of Lenris 4mg Capsule, as it may hinder wound healing and elevate the risk of bleeding.